To conclude, inhibitors of IRAP, such as Ang IV, improve memory and cognition in animal models, and the aminopeptidase IRAP is recognized as a new potential target for drugs aimed at treatment of cognitive disorders [2,9,16,17,18,19,37,38]. This evidence concerns the gene LNPEP and cognitive disorder.